Coleman Palliative Medicine Training Program
Coleman Palliative Medicine Training Program
October 2024-June 2025

DESCRIPTION
The goal of this activity is to improve the capacity of clinicians to provide palliative care of the highest quality to create better patient outcomes.
TARGET AUDIENCE
This activity is designed for physicians, physician assistants, advanced practice nurses, nurses, social workers, chaplains, and other healthcare professionals dedicated to delivering high-quality palliative care. Healthcare providers working with underserved populations and in under-resourced areas are encouraged to participate and will be offered scholarships.
LEARNING OBJECTIVES
After this activity, participants will be able to:
  • Recognize methods to support families suffering from grief and bereavement;
  • Identify the impact of cultural, social, and psychological health determinants on healthcare decision-making;
  • Define the challenges and barriers to accessing palliative care;
  • Describe productive team-based approaches to palliative care across the care continuum that support each discipline’s roles and contributions;
  • Discuss evidence-based approaches to managing gastrointestinal and respiratory symptoms in serious illness;
  • Develop an evidence-based approach to effectively manage pain in patients with serious illness, employing a comprehensive range of strategies including opioids, non-opioids, adjuvant analgesics, non-pharmacologic interventions, and alternative pharmacologic measures while prioritizing patient safety;
  • Determine the appropriateness of referring patients with serious illnesses to a mental health specialist;
  • Assess patient values and preferences for palliative care with a health equity lens;
  • Evaluate patients with serious illness for psychosocial distress, opioid risk, depression, and suicide risk;
  • Employ communication skills to effectively and empathetically deliver difficult news, and facilitate discussions about prognosis, goals of care, advance care planning, palliative care, and hospice care, while demonstrating cultural competence.
ACCREDITATION AND CREDIT DESIGNATION
Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Chicago Pritzker School of Medicine designates this Other activity (live/enduring) for a maximum of 52.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credit
University of Chicago Medicine is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
 
Participants who successfully complete the entire activity and complete an evaluation form will earn 45.5 contact hours.

Pharmacotherapy Credit
University of Chicago Medicine is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
 
Participants who successfully complete the entire activity and complete an evaluation form will earn 3.25 contact hours.

Social Worker Credit
University of Chicago Medicine is a Registered Social Work Continuing Education Sponsor through the Illinois Department of Financial and Professional Regulation and will offer continuing education units for the Cultural Competence Course for LSW and LCSW social workers in the state of Illinois.

19.75 social work continuing education units are provided for this activity.

Other Participant Credit
Other participants will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
EDUCATIONAL GRANTS/COMMERCIAL SUPPORT
This CME-certified activity has not requested or received any support or funding from commercial interests. This includes but is not limited to, pharmaceutical companies and medical device manufacturers.
DISCLOSURE DECLARATIONS
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
COURSE FACULTY AND PLANNERS
Magdalena Anitescu, MD, PhD, has served as a consultant for and has received research funding, and fellowship grant funding from Abbott, Boston Scientific, and Medtronic.

Aliza Baron, AM, owns stock in Eli Lilly and CVS.

Erin Zahradnik, MD, has served as a consultant for AbbVie.

No one else in a position to control the educational content of this activity has any relevant financial relationships with ineligible companies to disclose.

All of the relevant financial relationships listed for these individuals have been mitigated.
 
 
DISCLAIMER
The views expressed in this activity are those of the individual speaker. It should not be inferred or assumed that they are expressing the views of any pharmaceutical or product/device manufacturer, provider of commercial services, or The University of Chicago. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult the full prescribing information on any agent(s) presented in this activity for recommended dosage, indications, contraindications, warnings, precautions, and adverse effects before prescribing any medication. This is particularly important when a drug is new or infrequently prescribed.

Copyright ©2025 University of Chicago. All rights reserved including translation into other languages.  No part of this activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval systems, without permission in writing from The University of Chicago Center for Continuing Medical Education.

Please Note: Requests to claim credit after three months will be subject to additional fees.